Cultivation and Genomics Prove Long-Term Colonization of Donor's Bifidobacteria in Recurrent Clostridioides difficile Patients Treated With Fecal Microbiota Transplantation

dc.contributor.authorHanne Jouhten
dc.contributor.authorAki Ronkainen
dc.contributor.authorJuhani Aakko
dc.contributor.authorSeppo Salminen
dc.contributor.authorEero Mattila
dc.contributor.authorPerttu Arkkila
dc.contributor.authorReetta Satokari
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organizationfi=ravitsemus- ja ruokatutkimuskeskus|en=Nutrition and Food Research Center (NuFo)|
dc.contributor.organization-code1.2.246.10.2458963.20.12007811941
dc.contributor.organization-code2609200
dc.converis.publication-id49897275
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/49897275
dc.date.accessioned2022-10-28T13:56:09Z
dc.date.available2022-10-28T13:56:09Z
dc.description.abstractFecal microbiota transplantation (FMT) is an effective treatment for recurrentClostridioides difficileinfection (rCDI) and it's also considered for treating other indications. Metagenomic studies have indicated that commensal donor bacteria may colonize FMT recipients, but cultivation has not been employed to verify strain-level colonization. We combined molecular profiling ofBifidobacteriumpopulations with cultivation, molecular typing, and whole genome sequencing (WGS) to isolate and identify strains that were transferred from donors to recipients. SeveralBifidobacteriumstrains from two donors were recovered from 13 recipients during the 1-year follow-up period after FMT. The strain identities were confirmed by WGS and comparative genomics. Our results show that specific donor-derived bifidobacteria can colonize rCDI patients for at least 1 year, and thus FMT may have long-term consequences for the recipient's microbiota and health. Conceptually, we demonstrate that FMT trials combined with microbial profiling can be used as a platform for discovering and isolating commensal strains with proven colonization capacity for potential therapeutic use.
dc.identifier.eissn1664-302X
dc.identifier.olddbid185282
dc.identifier.oldhandle10024/168376
dc.identifier.urihttps://www.utupub.fi/handle/11111/50208
dc.identifier.urnURN:NBN:fi-fe2021042824345
dc.language.isoen
dc.okm.affiliatedauthorAakko, Juhani
dc.okm.affiliatedauthorSalminen, Seppo
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherFRONTIERS MEDIA SA
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.articlenumberARTN 1663
dc.relation.doi10.3389/fmicb.2020.01663
dc.relation.ispartofjournalFrontiers in microbiology
dc.relation.volume11
dc.source.identifierhttps://www.utupub.fi/handle/10024/168376
dc.titleCultivation and Genomics Prove Long-Term Colonization of Donor's Bifidobacteria in Recurrent Clostridioides difficile Patients Treated With Fecal Microbiota Transplantation
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
fmicb-11-01663.pdf
Size:
2.9 MB
Format:
Adobe Portable Document Format
Description:
Publisher's version